RadiDoseControl Portfolio | Acquisition Opportunity

RadiDoseControl Patent Portfolio

Precision ownership of radiation delivery

A defensible, system-level patent portfolio governing how radiation is delivered, positioned, and mapped inside the human body across modern oncology procedures. Developed by Dr. Mark D'Andrea.

14 Total Assets
7 US Patents Granted
7 International Assets

This portfolio controls the delivery layer of radiation therapy. In a field where precision defines outcomes, ownership of how radiation is deployed is no longer optional. It is strategic. Five technology families, mapped below like the isodose curves they help create, span diagnosis, positioning, and treatment delivery across gynecological, intracavitary, and body surface indications.

14
Total Patent Assets
7
US Grants
5
Technology Families
3
Jurisdictions

Five families. One coherent clinical platform.

Every asset, grouped by the clinical function it protects.

A
Tandem & Ovoid
The foundational system for intracavitary brachytherapy placement, with a detachable distal section for precise, repeatable positioning.
3 ASSETS
US 8,979,725

Brachytherapy tandem and ovoid implantation, the foundational system-level asset covering intracavitary radiation placement with a detachable distal section.

US · Granted
US 9,320,915

Continuation extending protection for tandem and ovoid implantation techniques, linked to the parent patent by terminal disclaimer.

US · Granted
CA 2,874,228

Brachytherapy tandem and ovoid implantation systems, granted for the Canadian market.

Canada · Granted

Note: US 8,979,725 and US 9,320,915 carry a terminal disclaimer and must transfer together.

B
Multi-Site Catheter
Simultaneous radiation delivery across multiple intracavitary treatment sites in a single procedure, reducing time under treatment.
3 ASSETS
US 9,149,653

Multi-site balloon catheter enabling simultaneous radiation delivery across multiple intracavitary treatment sites in a single procedure.

US · Granted
CA 2,902,707

Radiation delivery method improvements building on the multi-site catheter approach for the Canadian market.

Canada · Pending
MX/a/2015/011519

Therapeutic radiation delivery systems, allowed for the Mexican market.

Mexico · Allowed
C
Sheet Device
Flexible, conformable radiation treatment sheets for sarcomas and body surface indications, adapting to limbs, exposed cavities, and retroperitoneal sites.
4 ASSETS
US 9,604,074

Flexible sheet radiation treatment devices for sarcomas and body surface indications, conformable to limbs, surgically exposed cavities, and retroperitoneal sites.

US · Granted
US 10,207,127

Continuation extending sheet device protection with refined claim architecture covering the full surface treatment and hyperthermia combination workflow.

US · Granted
CA 2,846,715

Sheet technology for body surface radiation treatment, pending in Canada.

Canada · Pending
MX/a/2014/003102

Radiation sheet technology, allowed for the Mexican market.

Mexico · Allowed

Note: US 9,604,074 and US 10,207,127 carry a terminal disclaimer and must transfer together.

D
Mobile Balloon
A gynecological balloon device that slides longitudinally along a tandem and positions by inflation, with a cervix-conforming distal ring.
1 ASSET
US 10,086,213

Mobile gynecological balloon device sliding longitudinally along a tandem and positioning by inflation, with cervix-conforming distal ring and detachable single-use distal section.

US · Granted
E
Diagnostic Mapping
Real-time positioning intelligence before and during treatment, using movable spoke-mounted detectors to mark and map the treatment field.
3 ASSETS
US 9,192,345

Diagnostic mapping and marking system with movable spoke-mounted detectors for real-time positioning intelligence before and during treatment.

US · Granted
CA 2,904,896

Radiation diagnosis and treatment systems, pending in Canada.

Canada · Pending
MX/a/2015/011524

Radiation diagnosis systems, pending in Mexico.

Mexico · Pending

A rare opportunity to acquire control over a critical layer of oncology treatment infrastructure.

Contact for Acquisition Discussions

Managed by Aveli Consulting  ·  [email protected]

RadiDoseControl  ·  © 2026 Aveli Consulting